Инвестиции Titan Capital в индийскую компанию xStep для глобального доступа к нейрореабилитации

Founded by neuroscientist and biomedical engineer Parag Gad, xStep is built on nearly two decades of research in spinal neuromodulation carried out at the University of California, Los Angeles (UCLA). The company turns that research into rehabilitation technologies that clinics can use to help improve movement, strength, balance, sensation and functional recovery in people with neurological conditions. With the expansion of xStep, its non-invasive spinal neuromodulation platform, the company is helping India take an important step toward becoming a global hub for advanced neurorehabilitation. Neurological disorders are among the leading causes of long-term disability worldwide, yet access to advanced rehabilitation remains limited, especially in emerging markets. xStep is set on changing that by making its technology more affordable and easier to reach for patients and healthcare providers. Developed by SpineX Inc. (USA) and manufactured by VIVATRONIX Tech Pvt. Ltd. (India), xStep combines non-invasive spinal neuromodulation with structured rehabilitation. Unlike invasive approaches that require surgery, the technology delivers targeted electrical stimulation through electrodes placed on the skin over specific regions of the spinal cord, with therapy personalised to each patient's condition, functional goals and response to rehabilitation. The funding will support commercial expansion across India, manufacturing scale-up, clinical evidence generation and regulatory work in both domestic and international markets. As part of its next phase, xStep has launched xStep One, an integrated neurorehabilitation experience centre in Bengaluru. Through a collaboration with Trexo Robotics, it has also brought the company's wearable robotic gait trainer for children to India, making xStep One one of the first centres in the country to offer both xStep spinal neuromodulation and Trexo robotic gait training within a single integrated rehabilitation programme. Over the past year, xStep has grown from a research-focused company into a commercial one, building working relationships with clinicians, hospitals, researchers and rehabilitation centres in India and abroad. “For us, this has always been about access, not just technology. This investment validates our long-term vision of putting advanced neurorehabilitation within reach of patients everywhere,” said Parag Gad, Founder, CEO and inventor of xStep. “For too long, many of the most promising neurorehabilitation technologies have reached only a small number of patients. Titan Capital's backing gives us the support to scale manufacturing, widen clinical access and build strong evidence as we grow a company rooted in India with a global reach. We are grateful to Titan Capital, Kunal Bahl, Rohit Bansal and Manik Pasricha for believing in what we are building.” xStep's story goes back nearly two decades of research led by Gad at UCLA, where he worked alongside internationally recognised researchers studying how targeted electrical stimulation of the spinal cord could help restore movement after neurological injury and disease. Seeing that many of these technologies were expensive, invasive or stuck in research settings, he returned to India to build xStep and make this kind of rehabilitation more affordable and easier to access. The company is running more than 25 clinical studies, investigator collaborations and real-world evidence programmes in people living with spinal cord injury, stroke, cerebral palsy, multiple sclerosis and autonomic dysfunction across 20 countries. Commenting on the investment, Titan Capital spokesperson said, “At Titan Capital, we look for founders taking on large, real problems with strong science and solid execution. Parag Gad brings nearly two decades of neuroscience research and a clear plan to build a MedTech company from India for the world. What stood out about xStep was the mix of strong clinical evidence, real benefit for patients and a practical commercial plan. The company is building more than a single device. It is bringing together a full range of neurorehabilitation care that can change how neurological rehabilitation is delivered and improve the lives of patients and families worldwide.” Over the next 12-24 months, xStep plans to build up its manufacturing, expand clinical collaborations in India and abroad, add to the evidence across neurological disorders, and keep developing technologies that connect neuroscience research with day-to-day patient care. It also plans to work more closely with clinicians, hospitals and rehabilitation centres so that this kind of care reaches more patients.